11-17387103-T-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000525.4(KCNJ11):c.989A>G(p.Tyr330Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y330S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000525.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ11 | NM_000525.4 | c.989A>G | p.Tyr330Cys | missense_variant | 1/1 | ENST00000339994.5 | NP_000516.3 | |
KCNJ11 | NM_001166290.2 | c.728A>G | p.Tyr243Cys | missense_variant | 2/2 | NP_001159762.1 | ||
KCNJ11 | NM_001377296.1 | c.728A>G | p.Tyr243Cys | missense_variant | 3/3 | NP_001364225.1 | ||
KCNJ11 | NM_001377297.1 | c.728A>G | p.Tyr243Cys | missense_variant | 2/2 | NP_001364226.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ11 | ENST00000339994.5 | c.989A>G | p.Tyr330Cys | missense_variant | 1/1 | 6 | NM_000525.4 | ENSP00000345708.4 | ||
KCNJ11 | ENST00000528731.1 | c.728A>G | p.Tyr243Cys | missense_variant | 2/2 | 1 | ENSP00000434755.1 | |||
KCNJ11 | ENST00000682350.1 | c.728A>G | p.Tyr243Cys | missense_variant | 2/2 | ENSP00000508090.1 | ||||
KCNJ11 | ENST00000682764.1 | c.728A>G | p.Tyr243Cys | missense_variant | 2/3 | ENSP00000506780.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 67
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neonatal insulin-dependent diabetes mellitus Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Type 2 diabetes mellitus Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which is responsive to oral sulfonylureas. rs193929356 (c.989A>G, p.Y330C) of KCNJ11 is associated with early onset Type I Diabetes Mellitus. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 16, 2023 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNJ11 protein function. ClinVar contains an entry for this variant (Variation ID: 21204). This missense change has been observed in individual(s) with early onset diabetes (PMID: 15448107, 29361385, 32792356). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 330 of the KCNJ11 protein (p.Tyr330Cys). - |
Permanent neonatal diabetes mellitus Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at